Under construction – not a live service
Sign in
Taking people in SpainNo phase

Tests an AI tool on heart ECGs to spot transthyretin cardiac amyloidosis

Tests an AI platform reading heart tracings to detect cardiac amyloidosis in adults.

Plain-language title generated from the registry record
Registry title: Multicenter Study for the Validation of an AI-based ECG Platform for Early Cardiac Amyloidosis Diagnosis

Key facts

Where
Huelva, Palma de Mallorca, and San Sebastián, SpainSee the 3 sites

Where in Spain

  • Hospital Universitario Juan Ramon JimenezHuelva, SpainNo longer taking part
  • Hospital Universitario Son LlatzerPalma de Mallorca, SpainTaking people
  • Hospital Universitario DonostiaSan Sebastián, SpainNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Idoven 1903 S.L.
Trial code
NCT06978660
Record updated
4 November 2026
Original description
CONCERTO is a retrospective, observational, multicentric and single-arm study to perform an external validation of the cloud-based and AI-powered electrocardiogram (ECG) analysis platform, named Willem™, to detect Transthyretin cardiac amyloidosis (ATTR-CA). Thus, this study will assess Willem™ ability to distinguish between truly diagnosed ATTR-CA patients and confirmed non-ATTR-CA patients from ECG data.Read full original descriptionShow less

Multicenter Study for the Validation of an AI-based ECG Platform for Early Cardiac Amyloidosis Diagnosis (CONCERTO)

CONCERTO is a retrospective, observational, multicentric and single-arm study to perform an external validation of the cloud-based and AI-powered electrocardiogram (ECG) analysis platform, named Willem™, to detect Transthyretin cardiac amyloidosis (ATTR-CA). Thus, this study will assess Willem™ ability to distinguish between truly diagnosed ATTR-CA patients and confirmed non-ATTR-CA patients from ECG data.

Inclusion: Subjects ≥ 18 years old; Subjects with 12-leads ECG records with a 10 seconds minimum length on digital format.

Exclusion: Patients with paced rhythm on the ECG.

ClinicalTrials.gov NCT06978660